China Pharma Holdings (CPHI) Construction in Progress (2011 - 2015)
China Pharma Holdings (CPHI) posted Construction in Progress of $19747.0 for Q3 2015, up 234.92% on a QoQ basis from $5896.0 in Q2 2015, and down 99.84% year-over-year from $12.5 million in Q3 2014.
China Pharma Holdings (CPHI) Construction in Progress (2011 - 2015) Analysis & Trends
China Pharma Holdings' Construction in Progress history runs 5 years deep, the most recent figure standing at $19747.0 for Q3 2015.
- Quarterly Construction in Progress fell 99.84% year-over-year to $19747.0 in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $19747.0 (down 99.84% YoY) and the FY2014 annual result came in at $5848.0, down 99.98% from the prior year.
- Construction in Progress was $19747.0 for Q3 2015 at China Pharma Holdings, up from $5896.0 in the prior quarter.
- Across five years, Construction in Progress topped out at $29.7 million in Q2 2014 and bottomed at $5848.0 in Q4 2014.
- A 5-year average of $8.8 million and a median of $3.7 million in 2012 frame the typical range for Construction in Progress.
- Annual changes were most pronounced in 2013 — Construction in Progress surged 4227.86% — and 2015, when it tumbled 99.98%.
- China Pharma Holdings' Construction in Progress stood at $351571.0 in 2011, then soared by 949.17% to $3.7 million in 2012, then surged by 591.26% to $25.5 million in 2013, then slumped by 99.98% to $5848.0 in 2014, then jumped by 237.67% to $19747.0 in 2015.
- Business Quant data shows CPHI's Construction in Progress at $19747.0 in Q3 2015, $5896.0 in Q2 2015, and $5876.0 in Q1 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 19,747.00 |
| Jun 30, 2015 | 5,896.00 |
| Mar 31, 2015 | 5,876.00 |
| Dec 31, 2014 | 5,848.00 |
| Sep 30, 2014 | 12.54 Mn |
| Jun 30, 2014 | 29.72 Mn |
| Mar 31, 2014 | 29.01 Mn |
| Dec 31, 2013 | 25.50 Mn |
| Sep 30, 2013 | 15.67 Mn |
| Jun 30, 2013 | 10.34 Mn |
| Mar 31, 2013 | 4.13 Mn |
| Dec 31, 2012 | 3.69 Mn |
| Sep 30, 2012 | 361,999.00 |
| Jun 30, 2012 | 354,034.00 |
| Dec 31, 2011 | 351,571.00 |